In combination with PTEM and decapentaplegic homolog 7 (SMAP7), miR-216a/217 raises the stem-like cell population and promotes the metastatic ability of HCC cells through activating the PI3K/Akt and TGF-β pathways [53, 54]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.